Skip to main content
SpringerLink
Log in

Osteoporose bei chronisch entzündlichen Darmerkrankungen

  • Conference paper
Chronisch entzündliche Darmerkrankungen

Part of the book series: Gastroenterologie Update ((GASTROUPDATE,volume 2000))

  • 58 Accesses

Zusammenfassung

Gesteigerter Knochenmasseverlust und Osteoporose werden seit vielen Jahren als Komplikation chronisch entzündlicher Darmerkrankungen beschrieben (Clements et al. 1994). In den letzten Jahren sind sowohl auf dem Gebiet der Diagnostik als auch der Therapie der Osteoporose entscheidende Fortschritte erzielt worden. Die Verfahren zur Bestimmung der Knochendichte haben heute eine ausreichende Präzision und Sicherheit. Zum anderen stehen Medikamente zur Verfügung, die mehr vermögen als allein den Knochenmasseverlust aufzuhalten, nämlich eine Zunahme der Knochendichte bewirken können. Diese Übersicht fasst die aktuellen Kenntnisse zur Pathophysiologie, Pathogenese und Behandlung der mit der chronisch entzündlichen Darmerkrankung assoziierten Osteoporose zusammen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Andreassen H, Hylander E, Rix M (1999) Gender, age and body weight are the major predictive factors for bone mineral density in Crohn’s disease: a case-control cross-sectional study of 113 patients. American Journal of Gastroenterology 94: 824–828

    Article  PubMed  CAS  Google Scholar 

  • Andreassen H, Rungby J, Dahlerup JF (1997) Inflammatory bowel disease and osteoporosis. Scandinavian Journal of Gastroenterology 32: 1247–1255

    Article  PubMed  CAS  Google Scholar 

  • Baeksgaard L, Andersen KP, Hyldstrup L (1998) Calcium and vitamin D supplementation increases spinal BMD in healthy, postmenopausal women. Osteoporosis International 8: 255–260

    Article  PubMed  CAS  Google Scholar 

  • Bernstein CN, Seeger LL, Sayre JW, Anton PA, Artinian L, Shanahan F (1995) Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis. Journal of Bone and Mineral Research 10: 250–256

    Article  PubMed  CAS  Google Scholar 

  • Bischoff SC, Herrmann A, Göke M, Manns MP, von zur Mühlen A, Brabant G (1997) Altered Bone Metabolism in Inflammatory Bowel Disease. The American Journal of Gastroenterology 92: 1157–1163

    PubMed  CAS  Google Scholar 

  • Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, Bauer DC et al. (1996) Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. The Lancet 348: 1535–1541

    Article  CAS  Google Scholar 

  • Black DM, Reiss TF, Nevitt MC, Cauley J, Karpf D, Cummings SR (1993) Design of the Fracture Intervention Trial. Osteoporosis International 3: 29–39

    Article  Google Scholar 

  • Chapuy MC, Arlot ME, Duboeuf F (1992) Vitamin D3 and calcium to prevent hip fractures in elderly women. The New England Journal of Medicine 327: 1637–1642

    Article  PubMed  CAS  Google Scholar 

  • Clements D, Compston J (1994) Osteoporosis: A serious complication of inflammatory bowel disease. European Journal of Gastroenterology and Hepatology 1994: 757–760

    Article  Google Scholar 

  • Clements D, Compston JE, Evans WD, Rhodes J (1993) Hormone replacement therapy prevents bone loss in patients with inflammatory bowel disease. Gut 34: 1543–1546

    Article  PubMed  CAS  Google Scholar 

  • Clements D, Motley RD, Evans WD, Harries AD, Rhodes J, Coles RJ, Compston JE (1992) Longitudinal Study of Cortical Bone Loss in Patients with Inflammatory Bowel Disease. Scandinavian Journal of Gastroenterology 27: 1055–1060

    Article  PubMed  CAS  Google Scholar 

  • Compston JE, Judd D, Crawley EO, Evans WD, Evans C, Church HA, Reid EM, Rhodes J (1987) Osteoporosis in Patients with Inflammatory Bowel Disease. Gut 28: 410–415

    Article  PubMed  CAS  Google Scholar 

  • Croucher PI, Vedi S, Motley RJ, Garrahan NJ, Stanton MR, Compston JE (1993) Reduced bone formation in patients with osteoporosis associated with inflammatory bowel disease. Osteoporosis International 3: 236–241

    Article  PubMed  CAS  Google Scholar 

  • Cummings SR (1998) Prevention of hip fractures in older women: a population-based perspective. Osteoporosis International 1998: S8–S12

    Google Scholar 

  • Cummings SR, Black DM, Thomson DE, Applegate WB, Barrett-Connor E, Musliner TA, Palermo L (1998) Effect of alendronate on risk of fracture in women with low bone mineral density but without vertebral fractures. JAMA 280: 2077–2082

    Article  PubMed  CAS  Google Scholar 

  • Dinca M, Friew W, Luisetto G, Peccolo F, Bottega F, Leone L, Naccarato R, Martin A (1999) Evolution of osteopenia in inflammatory bowel disease. The American Journal of Gastroenterology 94: 1292–1997

    Article  PubMed  CAS  Google Scholar 

  • Edwards F, Truelove SC (1964) The course and prognosis of ulcerative colitis. Gut 5: 1–22

    Article  PubMed  CAS  Google Scholar 

  • Ensrud KE, Black DM, Palermo L, Bauer DC, Barrett-Connor E, Quandt SA, Thompson DE, Karpf DB (1997) Treatment with alendronate prevents fractures in women at highest risk. Archives of Internal Medicine 157: 2617–2624

    Article  PubMed  CAS  Google Scholar 

  • Filipponi P, Cristallini S, Rizzello E, Policani G, Fedeli L, Gregorio F, Boldrini S, Troiani S, Massoni C (1996) Cyclical intravenous clodronate in postmenopausal osteoporosis: results of a long-term clinical trial. Bone 18: 179–184

    Article  PubMed  CAS  Google Scholar 

  • Fleisch H (1998) Bisphosphonates: Mechanisms of Action. Endocrine Reviews 19: 80–100

    Article  PubMed  CAS  Google Scholar 

  • Fries W, Giacomin D, Plebani M, Martin A (1994) Effect of Experimental Colitis on Bone Metabolism in the Rat. Digestion 55: 229–233

    Article  PubMed  CAS  Google Scholar 

  • Fries W, Martin A (1997) IBD-associated bone loss: is inflammation the explanation Gastroenterology 112: 2161

    Article  PubMed  CAS  Google Scholar 

  • Ghosh S, Cowen S, Hannan WJ, Ferguson A (1994) Low bone mineral density in Crohn’s disease, but not in ulcerative colitis, at diagnosis. Gastroenterology 107: 1031–1039

    PubMed  CAS  Google Scholar 

  • Graham DY, Malaty HM (1999) Alendronate gastric ulcers. Alimentary and Pharmacologic therapy 13: 515–519

    Article  CAS  Google Scholar 

  • Graham DY, Malaty HM, Goodgame R (1997) Primary Amino-Bisphosphonates: A new class of gastrotoxic drugs - comparison of alendronate and aspirin. The American Journal of Gastroenterology 92: 1322–1325

    PubMed  CAS  Google Scholar 

  • Jahnsen J, Falch JA, Aadland E, Mowinckel P (1997) Bone mineral density is reduced in patients with Crohn’s disease but not in patients with ulcerative colitis: a population based study. Gut 40: 313–319

    PubMed  CAS  Google Scholar 

  • Jonsson B (1998) Targeting high-risk populations. Osteoporosis International 8: S13–S16

    Article  PubMed  Google Scholar 

  • Kanis JA (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report. Osteoporosis International 4: 368–381

    Article  PubMed  CAS  Google Scholar 

  • Lin C-L, Moniz C, Chambers TJ, Chow JWM (1996) Colitis Causes Bone Loss in Rats Through Suppression of Bone Formation. Gastroenterology 111: 1263–1271

    Article  PubMed  CAS  Google Scholar 

  • Meunier PJ, Sebert J-L, Reginster J-Y, Briancon D, Appelboom T, Netter P, Loeb G et al. (1998) Fluoride salts are no better at preventing new vertebral fractures than calcium-vitamin D in postmenopausal osteoporosis: the FAVOStudy. Osteoporosis International 8: 4–12

    Article  PubMed  CAS  Google Scholar 

  • Motley RJ, Clements D, Evans WD, Crawley EO, Evans C, Rhodes J, Compston JE (1993) A four- year longitudinal study of bone loss in patients with inflammatory bowel disease. Bone Miner 23: 95–104

    Article  PubMed  CAS  Google Scholar 

  • Neef B, Maier K-E, von Gaisberg U (1991) Schwere Osteoporose bei einer jungen Patientin mit Morbus Crohn. Dtsch Med Wschr 116: 1055–1060

    Article  PubMed  CAS  Google Scholar 

  • Pak CY, Sakhaee K, Piziak V, Peterson RD, Breslau NA, Boyd P, Poindexter BS et al. (1994) Slow- release sodium fluoride in the management of postmenopausal osteoporosis. A randomized controlled trial. Annals of Internal Medicine 120: 625–632

    PubMed  CAS  Google Scholar 

  • Pechersdorfer M, Ludwig H, Schlosser K, Buck S, Huss H-J, Body J-J (1996) Administration of the Bisphosphonate ibandronate (BM 21.0955) by Intravenous Bolus Injection. Journal of Bone and Mineral Research 11: 587–593

    Article  Google Scholar 

  • Pollak RD, Karmeli F, Eliakim R, Ackerman Z, Tabb K, Rachmilewitz D (1998) Femoral neck osteopenia in patients with inflammatory bowel disease. The American Journal of Gastroenterology 93: 1483–1490

    Article  PubMed  CAS  Google Scholar 

  • Riggs BL, O’Fallon WM, Muhs J, O’Connor MK, Kumar R, Melton LJI (1998) Long-term effects of calcium supplementation on serum parathyroid homrone level, bone turnover, and bone loss in elderly women. Journal of Bone and Mineral Research 13: 168–174

    Article  PubMed  CAS  Google Scholar 

  • Ringe JD, Meunier PJ (1995) What is the future for fluoride in the treatment of osteoporosis Osteoporosis International 5: 71–74

    Article  PubMed  CAS  Google Scholar 

  • Schulte C, Dignass AU, Mann K, Goebell H (1998) Reduced bone mineral density and unbalanced bone metabolism in patients with inflammatory bowel disease. Inflammatory Bowel Diseases 4 (4): 268–275

    Article  PubMed  CAS  Google Scholar 

  • Schulte C, Dignass AU, Mann K, Goebell H (1999) Bone loss in patients with inflammatory bowel disease is less than expected: A follow-up study. Scandinavian Journal of Gastroenterology 34: 696–702

    Article  PubMed  CAS  Google Scholar 

  • Schulte C, Hüsing J, Goebell H (2000) Individualizing the approach to a problem - IBD and osteoporosis. Persönliche Mitteilung Semao EJ, Stallings VA, Peck SN, Piccoli DA (1997) Vertebral compression fractures in pediatric patients with Crohn’s disease. Gastroenterology 112: 1710–1713

    Google Scholar 

  • Semao EJ, Stallings VA, Peck SN, Piccoli DA (1997) Vertrbral compression fractures in pediatric patients with Crohn’s disease. Gastroenterology 112: 1710–1713

    Article  Google Scholar 

  • Silvennoinen J, Risteli L, Karttunen T, Risteli J (1996) Increased degradation of type I collagen in patients with inflammatory bowel disease. Gut 38: 223–228

    Article  PubMed  CAS  Google Scholar 

  • Thiébaud D, Burckhardt P, Kriegbaum H, Huss H, Mulder H, Juttmann JR, Schoter KH (1997) Three monthly intravenous injections of ibandronate in the treatment of postmenopausal osteoporosis. American Journal of Medicine 103: 298–307

    Article  PubMed  Google Scholar 

  • Torgerson DJ, Kanis JA (1995) Cost-effectiveness of preventing hip fractures in the elderly population using vitamin D and calcium. The Quarterly Journal of Medicine 88: 135–139

    CAS  Google Scholar 

  • Valentine JF, Sninsky CA (1999) Prevention and treatment of osteoporosis in patients with inflammatory bowel disease. The American Journal of Gastroenterology 94: 878–883

    Article  PubMed  CAS  Google Scholar 

  • von Tirpitz C, Klaus J, Bruckel J, Rieber A, Scholer A, Adler G, Böhm B, Reinshagen M (2000) Increase of bone mineral density with sodium fluoride in patients with Crohn’s disease. European Journal of Gastroenterology and Hepatology 12: 19–24

    Article  Google Scholar 

  • von Tirpitz C, Pischulti G, Klaus J, Rieber A, Bruckel J, Böhm BO, Adler G, Reinshagen M (1999) Osteoporosis in patients with inflammatory bowel diseases - prevalence and risk factors. Zeitschrift für Gastroenterologie 37: 5–12

    Google Scholar 

Download references

Authors
  1. C. Schulte
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Campus Virchow-Klinikum Medizinische Klinik mit Schwerpunkt Hepatologie und Gastroenterologie, Universitätsklinik der Humboldt-Universität, Augustenburger Platz 1, 13353, Berlin, Deutschland

    Axel Dignass

  2. Medizinische Klinik II, Universitätsklinikum Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt/Main, Deutschland

    Jürgen Stein

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Schulte, C. (2001). Osteoporose bei chronisch entzündlichen Darmerkrankungen. In: Dignass, A., Stein, J. (eds) Chronisch entzündliche Darmerkrankungen. Gastroenterologie Update, vol 2000. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59556-1_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-59556-1_2

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-67722-2

  • Online ISBN: 978-3-642-59556-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation